Baudax Bio Inc 's

• BXRX's Stock Performance relative to its Competitors

Elite Pharmaceuticals Inc Share Performance -17.20% This Quarter

Elite Pharmaceuticals Inc Profile Elite Pharmaceuticals Inc. is a pharmaceutical company that specializes in developing and manufacturing generic and abuse-deterrent controlled-release products. Their business model focuses on conducting research, obtaining regulatory approvals, and licensing their products to other pharmaceutical companies for commercialization and distribution. More about Elite Pharmaceuticals Inc 's Market Share

Collegium Pharmaceutical Inc Share Performance -26.25% This Quarter

Collegium Pharmaceutical Inc Profile Collegium Pharmaceutical Inc's business model revolves around the development and commercialization of innovative products specifically designed to address the limitations of existing treatment options in pain management. They focus on developing extended-release formulations that offer abuse-deterrent properties to enhance patient safety and combat prescription drug abuse. By leveraging strategic partnerships, they aim to bring their products to market efficiently and effectively. More about Collegium Pharmaceutical Inc 's Market Share

Pacira Biosciences inc Share Performance +9.37% This Quarter

Pacira Biosciences inc Profile Pacira Biosciences Inc is a pharmaceutical company that focuses on the development and commercialization of non-opioid pain management products and treatments. More about Pacira Biosciences inc 's Market Share

Prf Technologies Ltd Share Performance -86.18% One Year

Prf Technologies Ltd Profile Painreform Ltd operates under a business model focused on developing and commercializing innovative pharmaceutical solutions for pain management. Their approach involves creating novel drug formulations and delivery systems to improve the efficacy, safety, and patient experience in treating acute and chronic pain. More about Prf Technologies Ltd 's Market Share

Jll Income Property Trust Inc Share Performance -0.27% This Year

Jll Income Property Trust Inc Profile JLL Income Property Trust Inc is a real estate investment trust (REIT) that focuses on acquiring and managing a diverse portfolio of income-producing properties. The company generates revenue through rental income from its properties, which include office, industrial, retail, and multifamily assets across the United States. JLL Income Property Trust Inc aims to provide stable cash flows and long-term growth opportunities to its shareholders through prudent acquisitions, active asset management, and portfolio diversification. More about Jll Income Property Trust Inc 's Market Share

Sources: Baudax Bio Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 11:29 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Baudax Bio Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.